EARLY VIROLOGICAL RESPONSE IS THE MAIN PREDICTOR OF VIRAL ERADICATION IN HCV HAEMODIALYSIS PATIENTS TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN

被引：0
|
作者：
Rendina, M. [1 ]
Tucci, A. [1 ]
Castellaneta, A. [1 ]
Castellaneta, N. M. [1 ]
Chiala', C. [1 ]
Leandro, G. [2 ]
Gesualdo, L. [3 ]
Di Leo, A. [1 ]
机构：
[1] Univ Hosp, Gastroenterol & Digest Endoscopy, Bari, Italy
[2] IRCCS Castellana Grotte, Div Gastroenterol, Castellana Grotte, Italy
[3] Univ Hosp, Nephrol & Dialysis, Bari, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2014年 / 46卷
关键词：
D O I：
10.1016/S1590-8658(14)60033-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC.04.6
引用
收藏
页码：S12 / S13
页数：2
相关论文
共 50 条
  • [41] Impact of Diet and Exercise Intervention On Insulin Resistance and Early Virological Response to Pegylated Interferon Plus Ribavirin in Patients with Chronic Hepatitis C
    Kawaguchi, Yasunori
    Mizuta, Toshihiko
    Kuwashiro, Takuya
    Oza, Noriko
    Takahashi, Hirokazu
    Eguchi, Yuichiro
    Ozaki, Iwata
    Fujimoto, Kazuma
    GASTROENTEROLOGY, 2009, 136 (05) : A791 - A791
  • [42] Coadministration of ezetimibe with pegylated interferon plus ribavirin could improve early virological response in chronic hepatitis C obese Egyptian patients
    Helal, Gouda K.
    Gad, Magdy A.
    Abd-Ellah, Mohamed F.
    Mahgoup, Elsayed M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (05) : 553 - 557
  • [43] Viral kinetics of HCV genotype 5 in South African patients treated with pegylated-interferon-alfa and ribavirin
    Nieuwoudt, Martin
    Arazi, Amon
    Neumann, Avidan U.
    Song, Ernie
    van der Merwe, Schalk
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2007, 97 (08): : 608 - 609
  • [44] Differences in virological response to pegylated interferon and ribavirin between hepatitis C virus (HCV)-monoinfected and HCV-HIV-coinfected patients
    Tural, Cristina
    Galeras, Josep Anton
    Planas, Ramon
    Coll, Susanna
    Sirera, Guillem
    Gimenez, Dolors
    Salas, Anna
    Rey-Joly, Celestino
    Cirera, Isabel
    Marquez, Carmen
    Tor, Jordi
    Videla, Sebostia
    Garcia-Retortillo, Montserrat
    Clotet, Bonaventura
    Sola, Ricard
    ANTIVIRAL THERAPY, 2008, 13 (08) : 1047 - 1055
  • [45] Cytokine response in chronic hepatitis C (CHC) patients treated with pegylated interferon plus ribavirin
    Trapero-Marugan, M.
    Garcia-Buey, L.
    Munoz, C.
    Moreno-Monteagudo, J. A.
    Borque, M. J.
    Salcedo-Mora, X.
    Moreno-Otero, R.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S227 - S228
  • [46] Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
    Abbas, Zaigham
    Tayyab, Ghiasun Nabi
    Qureshi, Mustafa
    Memon, Mohammad Sadik
    Subhan, Amna
    Shakir, Tanzila
    Jafri, Wasim
    Hamid, Saeed
    HEPATITIS MONTHLY, 2013, 13 (12)
  • [47] Use of erythropoietin increases the likelihood of achieving viral clearance in HCV infected patients treated with pegylated interferon and ribavirin
    Poordad, F
    Tran, TT
    Patel, Y
    Ayoub, W
    Newland, K
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S131 - S131
  • [48] Viral kinetics of HCV genotype 5 in South African patients treated with pegylated-interferon-alfa and ribavirin
    Nieuwoudt, Martin
    Arazi, Arnon
    Neumann, Avidan U.
    von Merwe, Schalk
    HEPATOLOGY, 2007, 46 (04) : 367A - 367A
  • [49] Cytokine response in chronic hepatitis C (CHC) patients treated with pegylated interferon plus ribavirin
    Marugán, MT
    Moreno-Otero, R
    Garcia-Buey, L
    Moreno-Monteagudo, JA
    Vitón, M
    Muñoz, C
    Borque, MJ
    Salcedo-Mora, X
    HEPATOLOGY, 2005, 42 (04) : 668A - 668A
  • [50] Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort
    Righi, E.
    Beltrame, A.
    Bassetti, M.
    Lindstrom, V.
    Mazzarello, G.
    Dentone, C.
    Di Biagio, A.
    Ratto, S.
    Viscoli, C.
    INFECTION, 2008, 36 (04) : 358 - 361
12345